|

KB408 (Nebulization) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Krystal Biotech, Inc.1

Indications

  • Alpha 1-Antitrypsin Deficiency1
  • Liver Disease1

Gainesville, Florida1 trial

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

University of Florida, Gainesville

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.